BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6878975)

  • 1. [Should asymptomatic hyperuricemia be treated?].
    Gerster JC
    Rev Med Suisse Romande; 1983 May; 103(5):457-60. PubMed ID: 6878975
    [No Abstract]   [Full Text] [Related]  

  • 2. [Asymptomatic hyperuricaemia: to treat or not to treat? (author's transl)].
    Gerber NJ
    Schweiz Rundsch Med Prax; 1981 Nov; 70(47):2111-6. PubMed ID: 7053145
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation and treatment of hyperuricemia].
    Wolfram G
    Med Welt; 1973 Dec; 24(50):1969-73. PubMed ID: 4776217
    [No Abstract]   [Full Text] [Related]  

  • 4. [Uninterrupted therapy of hyperuricemia and gout].
    Schilling F
    Reumatizam; 1971; 18(3):79-82. PubMed ID: 5097291
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical significance of hyperuricemia.
    Seegmiller JE
    Med Ann Dist Columbia; 1967 Apr; 36(4):215-8. PubMed ID: 5232849
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of hyperuricemia].
    Gröbner W
    Verh Dtsch Ges Inn Med; 1986; 92():492-7. PubMed ID: 3811551
    [No Abstract]   [Full Text] [Related]  

  • 7. Should asymptomatic hyperuricaemia be treated?
    Jeremy R
    Med J Aust; 1972 Aug; 2(9):505-6. PubMed ID: 5083604
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperuricemia and gout; treatment of an acute attack of gout].
    Gast LF; Cats A; van Romunde LK
    Ned Tijdschr Geneeskd; 1983 Dec; 127(49):2235-7. PubMed ID: 6656915
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperuricemia due to hypoxanthine-guanine-phosphoribosyltransferase deficiency].
    Blétry O; Cartier P; Hamet M; Clauvel JP
    Nouv Presse Med; 1974 Apr; 3(16):995-9. PubMed ID: 4836472
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Missed gout].
    Rückert KH; Chowanetz W
    Munch Med Wochenschr; 1972 Apr; 114(14):663-5. PubMed ID: 5067879
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperuricemia and benziodarone].
    Haddad N; Zamouri A; Naccache S
    Tunis Med; 1973; 51(2):103-4. PubMed ID: 4784400
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of asymptomatic hyperuricemia.
    Duffy WB; Senekjian HO; Knight TF; Weinman EJ
    JAMA; 1981 Nov; 246(19):2215-6. PubMed ID: 7289015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperuricemia and gout: an update.
    Khachadurian AK
    Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of hyperuricemia in gout.
    Rastegar A; Thier SO
    Ration Drug Ther; 1974 Mar; 8(3):1-4. PubMed ID: 4820829
    [No Abstract]   [Full Text] [Related]  

  • 17. [When and how to treat hyperuricemia].
    Rubens-Duval A
    Therapeutique; 1973 Apr; 49(4):263-5. PubMed ID: 4775219
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis and therapy of gout and hyperuricemia].
    Guzmán L
    Rev Med Chil; 1981 Dec; 109(12):1191-7. PubMed ID: 7346920
    [No Abstract]   [Full Text] [Related]  

  • 19. [Benziodarone therapy in hyperuricemia in the aged].
    Ravera M; Ugo C
    G Gerontol; 1970 Sep; 18(9):876-9. PubMed ID: 5517231
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gout].
    Gröbner W; Zöllner N
    Z Rheumatol; 2004 Feb; 63(1):2-9. PubMed ID: 14991273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.